1. Home
  2. MASS vs ABEO Comparison

MASS vs ABEO Comparison

Compare MASS & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$6.88

Market Cap

241.4M

Sector

Health Care

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.12

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MASS
ABEO
Founded
2012
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.4M
280.2M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
MASS
ABEO
Price
$6.88
$5.12
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$18.20
AVG Volume (30 Days)
265.4K
952.2K
Earning Date
04-20-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.74
EPS
0.43
1.35
Revenue
$59,631,000.00
$2,998,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$19.55
$1,589.77
P/E Ratio
$16.23
$3.86
Revenue Growth
18.72
258.18
52 Week Low
$1.92
$3.93
52 Week High
$9.34
$7.54

Technical Indicators

Market Signals
Indicator
MASS
ABEO
Relative Strength Index (RSI) 57.97 47.69
Support Level $6.19 $4.87
Resistance Level $7.42 $5.60
Average True Range (ATR) 0.37 0.20
MACD 0.00 0.01
Stochastic Oscillator 74.19 28.46

Price Performance

Historical Comparison
MASS
ABEO

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: